Oxidative stress and disturbed glutamate transport in spinal muscular atrophy

Brain and Development

Volumn 24, Issue 8, 2002, Pages 770-775

  Hayashi, Masaharu ^a   Araki, Satoshi ^b   Arai, Nobutaka ^a   Kumada, Satoko ^a   Itoh, Masahiro ^a   Tamagawa, Kimiko ^b   Oda, Masaya ^b   Morimatsu, Yoshio ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

Author keywords

4 Hydroxy 2 nonenal modified protein; 8 Hydroxy 2 deoxyguanosine; Glutamate transporter; Oxidative stress; Spinal muscular atrophy; Thalamic degeneration; Werdnig Hoffmann disease

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMATE TRANSPORTER; MEMBRANE LIPID;

ADULT; AMINO ACID TRANSPORT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ARTIFICIAL VENTILATION; AUTOPSY; AUTOSOMAL RECESSIVE DISORDER; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM; CEREBELLUM CORTEX; CHILD; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE DELETION; GLIA CELL; GLIOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MOTOR NEURON DISEASE; NERVE CELL; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN MODIFICATION; SPINAL CORD MOTONEURON; SPINAL MUSCULAR ATROPHY; THALAMUS; THALAMUS VENTRAL NUCLEUS; WERDNIG HOFFMANN DISEASE;

ADOLESCENT; ADULT; AMINO ACID TRANSPORT SYSTEM X-AG; BRAIN; CELL DEATH; CENTRAL NERVOUS SYSTEM; CHILD; CHILD, PRESCHOOL; EXCITATORY AMINO ACID TRANSPORTER 2; FEMALE; GLUTAMIC ACID; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MOTOR NEURONS; MUSCULAR ATROPHY, SPINAL; NEURONS; OXIDATIVE STRESS; SPINAL CORD;

EID: 0036890669     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(02)00103-1     Document Type: Article

References (19)

1. Dubowitz V. Disorders of the lower motor neurone. The spinal muscular atrophy. Dubowitz V., Muscle disorders in childhood. 2nd ed. 1995;325-369 Saunders, London.
2. Osawa M., Shishikura K. Werdnig-Hoffmann disease and variants. de Jong J.M.B.D., Disease of the motor system. Handbook of clinical neurology. 1991;51-80 Elsevier, Amsterdam.
3. Lefebvre S., Bürglen L., Reboullet S., Clermont O., Burlet P., Viollet L., et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 80:1995;155-165.
4. Roy N., Mahadevan M.S., McLean M., Shutler G., Yaraghi Z., Farahani R., et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell. 80:1995;167-178.
5. Stewart H., Wallace A., McGaughran J., Mountford R., Kingston H. Molecular diagnosis of spinal muscular atrophy. Arch Dis Child. 78:1998;531-535.
6. Hayashi M., Arai N., Murakami T., Morimatsu Y., Oda M., Matsuyama H. A study of cell death in Werdnig-Hoffmann disease brain. Neurosci Lett. 243:1998;117-120.
7. Simic G., Seso-Simic D., Lucassen P.J., Islam A., Krsnik Z., Cviko A., et al. Ultrastructural analysis and TUNEL demonstrate motor neuron apoptosis in Werdnig-Hoffmann disease. J Neuropathol Exp Neurol. 59:2000;398-407.
8. Beal M.F., Ferrante R.J., Browne S.E., Matthews R.T., Kowall N.W., Brown R.H. Jr. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol. 42:1997;644-654.
9. Rothstein J.D., van Kammen M., Levey A.I., Martin L.J., Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol. 38:1995;73-84.
10. Takedo A., Yasuda T., Miyata T., Mizuno K., Li M., Yoneyama S., et al. Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain. Neurosci Lett. 221:1996;17-20.
11. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E.R., Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA. 93:1996;2696-2701.
12. Sayre L.M., Zelasko D.A., Harris P.L.R., Perry G., Salomon R.G., Smith M.A. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem. 68:1997;2092-2097.
13. Hayashi M., Itoh M., Araki S., Kumada S., Shioda K., Tamagawa K., et al. Oxidative stress and disturbed glutamate transport in hereditary nucleotide repair disorders. J Neuropathol Exp Neurol. 60:2001;350-356.
14. Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int. 49:1999;91-102.
15. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol. 60:2001;759-767.
16. Rothstein J.D., Martin L.J., Levey A.I., Dykes-Hoberg M., Jin L., Wu D., et al. Localization of neuronal and glial transporters. Neuron. 13:1994;713-725.
17. Bar-Peled O., Ben-Hur H., Biegon A., Alford M., Tanaka S., Masliah E. Distribution of glutamate transporter subtypes during human brain development. J Neurochem. 69:1997;2571-2580.
18. Li S., Mallory M., Alford M., Tanaka S., Masliah E. Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol. 56:1997;901-911.
19. Ludolph A.C., Riepe M.W. Do the benefits of currently available treatments justify early diagnosis and treatment of amyotrophic lateral sclerosis? Neurology. 53:(Suppl 5):1999;S46-S49.